Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Jan;41(1):80–84. doi: 10.1128/aac.41.1.80

Treatment of human brucellosis with doxycycline and gentamicin.

J Solera 1, A Espinosa 1, E Martínez-Alfaro 1, L Sánchez 1, P Geijo 1, E Navarro 1, J Escribano 1, J A Fernández 1
PMCID: PMC163664  PMID: 8980759

Abstract

The objective of the present prospective, noncomparative, multicenter study was assess the safety and efficacy of gentamicin and doxycycline therapy for human brucellosis. In the first part of the study, a cohort of 17 patients received 100 mg of doxycycline (or 50 mg/kg of body weight per day if the body weight was < 40 kg) orally every 12 h for 45 days (cohort 1). In the second part of the study a subsequent cohort of 35 patients was treated with doxycycline at the same dosage for 30 days (cohort 2). All patients were treated intramuscularly with gentamicin at 240 mg (or 5 mg/kg per day if the body weight was < 50 kg) once daily for the first 7 days. Both cohorts showed a favorable response during therapy, and there were no therapeutic failures. Relapse was noted in 1 (5.9%; 95% confidence interval [95% CI], 0.15 to 28.7%) of the 17 patients in cohort 1 and in 8 (22.9%; 95% CI, 10.4 to 40.1%) of the 35 patients in cohort 2. Nineteen patients (36.5%; 95% CI, 23.6 to 51.0%) had adverse effects, with no differences between cohorts, and no patients had a treatment-limiting adverse effect. The study indicates that the combination of doxycycline for 45 days and gentamicin for 7 days is an effective and well-tolerated therapy for human brucellosis. The relapse rates obtained with doxycycline treatment for 30 days appear to be higher than those obtained with doxycycline treatment for 45 days.

Full Text

The Full Text of this article is available as a PDF (170.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acocella G., Bertrand A., Beytout J., Durrande J. B., Garcia Rodriguez J. A., Kosmidis J., Micoud M., Rey M., Rodriguez Zapata M., Roux J. Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother. 1989 Mar;23(3):433–439. doi: 10.1093/jac/23.3.433. [DOI] [PubMed] [Google Scholar]
  2. Ariza J., Gudiol F., Pallares R., Viladrich P. F., Rufi G., Corredoira J., Miravitlles M. R. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med. 1992 Jul 1;117(1):25–30. doi: 10.7326/0003-4819-117-1-25. [DOI] [PubMed] [Google Scholar]
  3. Ariza J., Gudiol F., Pallarés R., Rufí G., Fernández-Viladrich P. Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis. J Infect Dis. 1985 Dec;152(6):1358–1359. doi: 10.1093/infdis/152.6.1358. [DOI] [PubMed] [Google Scholar]
  4. Ariza J., Gudiol F., Pallarés R., Rufí G., Fernández-Viladrich P. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother. 1985 Oct;28(4):548–551. doi: 10.1128/aac.28.4.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chan R., Hardiman R. P. Endocarditis caused by Brucella melitensis. Med J Aust. 1993 May 3;158(9):631–632. doi: 10.5694/j.1326-5377.1993.tb137636.x. [DOI] [PubMed] [Google Scholar]
  6. Cisneros J. M., Viciana P., Colmenero J., Pachón J., Martinez C., Alarcón A. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Antimicrob Agents Chemother. 1990 May;34(5):881–883. doi: 10.1128/aac.34.5.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Colmenero Castillo J. D., Hernandez Marquez S., Reguera Iglesias J. M., Cabrera Franquelo F., Rius Diaz F., Alonso A. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy. 1989;35(2):146–152. doi: 10.1159/000238662. [DOI] [PubMed] [Google Scholar]
  8. De Leenheer A. P., Nelis H. J. Doxycycline determination in human serum and urine by high-performance liquid chromatography. J Pharm Sci. 1979 Aug;68(8):999–1002. doi: 10.1002/jps.2600680821. [DOI] [PubMed] [Google Scholar]
  9. Feiz J. M., Sabbaghian H., Sohrabi F. A comparative study of therapeutic agents used for treatment of acute brucellosis. Br J Clin Pract. 1973 Nov;27(11):410–413. [PubMed] [Google Scholar]
  10. Gargani G., Pacetti A. M. Sensitivity of 115 strains of the genus Brucella to some antibiotics (cephalosporins, ureidopenicillins and aminoglycosides). Chemioterapia. 1986 Feb;5(1):7–13. [PubMed] [Google Scholar]
  11. Hall W. H. Modern chemotherapy for brucellosis in humans. Rev Infect Dis. 1990 Nov-Dec;12(6):1060–1099. doi: 10.1093/clinids/12.6.1060. [DOI] [PubMed] [Google Scholar]
  12. Lubani M. M., Dudin K. I., Sharda D. C., Ndhar D. S., Araj G. F., Hafez H. A., al-Saleh Q. A., Helin I., Salhi M. M. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989 Feb;8(2):75–78. [PubMed] [Google Scholar]
  13. MAGILL G. B., KILLOUGH J. H. Oxytetracycline-streptomycin therapy in brucellosis due to Brucella melitensis. AMA Arch Intern Med. 1953 Feb;91(2):204–211. doi: 10.1001/archinte.1953.00240140064005. [DOI] [PubMed] [Google Scholar]
  14. Montejo J. M., Alberola I., Glez-Zarate P., Alvarez A., Alonso J., Canovas A., Aguirre C. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis. 1993 May;16(5):671–676. doi: 10.1093/clind/16.5.671. [DOI] [PubMed] [Google Scholar]
  15. Novotný Z., Moeschlin S. Klinische Erfahrungen mit dem Breitspektrumantibiotikum Gentamizin (1969-1970. Schweiz Med Wochenschr. 1972 Jan 8;102(1):24–29. [PubMed] [Google Scholar]
  16. Pedro-Botet J., Coll J., Auguet T., Rubiés-Prat J. Brucellosis and HIV infection: a casual association? AIDS. 1992 Sep;6(9):1039–1040. doi: 10.1097/00002030-199209000-00020. [DOI] [PubMed] [Google Scholar]
  17. Qadri S. M., al-Sedairy S., Ueno Y. Antibacterial activity of lomefloxacin against Brucella melitensis. Diagn Microbiol Infect Dis. 1990 May-Jun;13(3):277–279. doi: 10.1016/0732-8893(90)90074-6. [DOI] [PubMed] [Google Scholar]
  18. SPINK W. W. HOST-PARASITE RELATIONSHIP IN BRUCELLOSIS. Lancet. 1964 Jul 25;2(7352):161–164. doi: 10.1016/s0140-6736(64)90228-4. [DOI] [PubMed] [Google Scholar]
  19. Solera J., Espinosa A., Geijo P., Martínez-Alfaro E., Sáez L., Sepúlveda M. A., Ruiz-Ribó M. D. Treatment of human brucellosis with netilmicin and doxycycline. Clin Infect Dis. 1996 Mar;22(3):441–445. doi: 10.1093/clinids/22.3.441. [DOI] [PubMed] [Google Scholar]
  20. Solera J., Medrano F., Rodríguez M., Geijo P., Paulino J. Ensayo terapéutico comparativo y multicéntrico de rifampicina y doxiciclina frente a estreptomicina y doxiciclina en la brucelosis humana. Med Clin (Barc) 1991 May 4;96(17):649–653. [PubMed] [Google Scholar]
  21. Solera J., Rodríguez-Zapata M., Geijo P., Largo J., Paulino J., Sáez L., Martínez-Alfaro E., Sánchez L., Sepulveda M. A., Ruiz-Ribó M. D. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Chemother. 1995 Sep;39(9):2061–2067. doi: 10.1128/aac.39.9.2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Todd K. H., Lyde P. D. Brucellosis and thrombocytopenic purpura: case report and review. Tex Med. 1989 Mar;85(3):37–38. [PubMed] [Google Scholar]
  23. Valladares M., Viciana P., Martín A., del Nozal M. Brucelosis aguda e infección por VIH: una nueva particularidad. Enferm Infecc Microbiol Clin. 1993 Nov;11(9):511–512. [PubMed] [Google Scholar]
  24. Waitz J. A., Weinstein M. J. Recent microbiological studies with gentamicin. J Infect Dis. 1969 Apr-May;119(4):355–360. doi: 10.1093/infdis/119.4-5.355. [DOI] [PubMed] [Google Scholar]
  25. Young E. J. An overview of human brucellosis. Clin Infect Dis. 1995 Aug;21(2):283–290. doi: 10.1093/clinids/21.2.283. [DOI] [PubMed] [Google Scholar]
  26. Young E. J. Human brucellosis. Rev Infect Dis. 1983 Sep-Oct;5(5):821–842. doi: 10.1093/clinids/5.5.821. [DOI] [PubMed] [Google Scholar]
  27. al-Kasab S., al-Fagih M. R., al-Yousef S., Ali Khan M. A., Ribeiro P. A., Nazzal S., al-Zaibag M. Brucella infective endocarditis. Successful combined medical and surgical therapy. J Thorac Cardiovasc Surg. 1988 May;95(5):862–867. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES